Affect Therapeutics, a substance addiction therapy startup, has raised $16 million in a Series A funding round to expand its operations to new markets and further develop its mobile app.
The McLean, Virginia company delivers therapy and treatments for specific substance use disorders, including alcohol, marijuana, methamphetamine and prescription stimulants, through its app. Counseling services — from individual therapy to group meeting to doctor visits — are done through video on the app…
